This article needs additional citations for verification. (September 2017) (Learn how and when to remove this template message)
An echocardiogram, often referred to as a cardiac echo or simply an echo, is a sonogram of the heart. (It is not abbreviated as ECG, because that is an abbreviation for an electrocardiogram.) Echocardiography uses standard two-dimensional, three-dimensional, and Doppler ultrasound to create images of the heart.
Echocardiography has become routinely used in the diagnosis, management, and follow-up of patients with any suspected or known heart diseases. It is one of the most widely used diagnostic tests in cardiology. It can provide a wealth of helpful information, including the size and shape of the heart (internal chamber size quantification), pumping capacity, and the location and extent of any tissue damage. An echocardiogram can also give physicians other estimates of heart function, such as a calculation of the cardiac output, ejection fraction, and diastolic function (how well the heart relaxes).
Echocardiography is an important tool in assessing Wall motion abnormality in suspected patients of cardiac disease. It is an early tool which helps in reaching a diagnosis of Myocardial infarction showing regional wall motion abnormality of the heart. Also, its important in treatment and followup in patients of Heart failure by assessing Ejection fraction.
Echocardiography can help detect cardiomyopathies, such as hypertrophic cardiomyopathy, dilated cardiomyopathy, and many others. The use of stress echocardiography may also help determine whether any chest pain or associated symptoms are related to heart disease. The biggest advantage to echocardiography is that it is not invasive (does not involve breaking the skin or entering body cavities) and has no known risks or side effects.
Not only can an echocardiogram create ultrasound images of heart structures, but it can also produce accurate assessment of the blood flowing through the heart by Doppler echocardiography, using pulsed- or continuous-wave Doppler ultrasound. This allows assessment of both normal and abnormal blood flow through the heart. Color Doppler, as well as spectral Doppler, is used to visualize any abnormal communications between the left and right sides of the heart, any leaking of blood through the valves (valvular regurgitation), and estimate how well the valves open (or do not open in the case of valvular stenosis). The Doppler technique can also be used for tissue motion and velocity measurement, by tissue Doppler echocardiography.
Echocardiography was also the first ultrasound subspecialty to use intravenous contrast. Echocardiography is performed by cardiac sonographers, cardiac physiologists (UK), or physicians trained in echocardiography.
Recognized as the “Father of Echocardiography”, the Swedish physician Inge Edler (1911-2001), a graduate of Lund University, was the first of his profession to apply ultrasonic pulse echo imaging in diagnosing cardiac disease, which the acoustical physicist Floyd Firestone had developed to detect defects in metal castings. In fact, Edler in 1953 produced the first echocardiographs using an industrial Firestone-Sperry Ultrasonic Reflectoscope. In developing echocardiography, Edler worked with the physicist Carl Hellmuth Hertz, the son of the Nobel laureate Gustav Hertz and grandnephew of Heinrich Rudolph Hertz.
Health societies recommend the use of echocardiography for initial diagnosis when a change in the patient's clinical status occurs and when new data from an echocardiogram would result in the physician changing the patient's care. Health societies do not recommend routine testing when the patient has no change in clinical status or when a physician is unlikely to change care for the patient based on the results of testing.
A common example of overuse of echocardiography when not indicated is the use of routine testing in response to a patient diagnosis of mild valvular heart disease. In this case, patients are often asymptomatic for years before the onset of deterioration and the results of the echocardiogram would not result in a change in care without other change in clinical status.
Echocardiography now has vast role in Pediatrics diagnosing patient of Valvular heart disease and other congenital abnormalities. Now an emerging branch of Echo is also seen as Fetal echocardiography which involves Echocardiography of unborn fetus by the use of Ultrasonic Waves with no known side effects to mother and fetus.
Types of echocardiographyEdit
A standard echocardiogram is also known as a transthoracic echocardiogram, or cardiac ultrasound. In this case, the echocardiography transducer (or probe) is placed on the chest wall (or thorax) of the subject, and images are taken through the chest wall. This is a noninvasive, highly accurate, and quick assessment of the overall health of the heart.
This is an alternative way to perform an echocardiogram. A specialized probe containing an ultrasound transducer at its tip is passed into the patient's esophagus. This allows image and Doppler evaluation from a location directly behind the heart. This is known as a transesophageal echocardiogram. Transesophageal echocardiograms are most often used when transthoracic images are suboptimal and when a more clear and precise image is needed for assessment. This test is performed in the presence of a cardiologist, registered nurse, and ultrasound technician. Conscious sedation and/or localized numbing medication may be used to make the patient more comfortable during the procedure.
A stress echocardiogram, also known as a stress echo, uses ultrasound imaging of the heart to assess the wall motion in response to physical stress. First, images of the heart are taken "at rest" to acquire a baseline of the patient's wall motion at a resting heart rate. The patient then walks on a treadmill or uses another exercise modality to increase the heart rate to his or her target heart rate, or 85% of the age-predicted maximum heart rate (220 − patient's age). Finally, images of the heart are taken "at stress" to assess wall motion at the peak heart rate. A stress echo assesses wall motion of the heart; it does not, however, create an image of the coronary arteries directly. Ischemia of one or more coronary arteries could cause a wall motion abnormality, which could indicate coronary artery disease. The gold standard test to directly create an image of the coronary arteries and directly assess for stenosis or occlusion is a cardiac catheterization. A stress echo is not invasive and is performed in the presence of a licensed medical professional, such as a cardiologist, and a cardiac sonographer.
Intracardiac echocardiography (ICE) is specialized form of echocardiography that uses catheters to insert the ultrasound probe inside the heart to view 2D structures from within.
Intravascular ultrasound (IVUS) is a specialized form of echocardiography that uses a catheter to insert the ultrasound probe inside blood vessels. This is commonly used to measure the size of blood vessels and to measure the internal diameter of the blood vessel. For example, this can be used in a coronary angiogram to assess the narrowing of the coronary artery. If the catheter is retraced in a controlled manner, then an internal map can be generated to see the contour of the vessel and its branches.
Strain rate imaging (deformation echocardiography)Edit
Strain rate imaging is an ultrasound method for imaging regional differences in contraction (dyssynergy) in for instance iscemic heart disease or dyssynchrony due to Bundle branch block. Strain rate imaging measures either regional systolic deformation (strain) or the rate of regional deformation (strain rate). The methods used are either tissue Doppler or Speckle tracking echocardiography.
Three-dimensional echocardiography (also known as four-dimensional echocardiography when the picture is moving) is now possible, using a matrix array ultrasound probe and an appropriate processing system. This enables detailed anatomical assessment of cardiac pathology, particularly valvular defects, and cardiomyopathies. The ability to slice the virtual heart in infinite planes in an anatomically appropriate manner and to reconstruct three-dimensional images of anatomic structures make it unique for the understanding of the congenitally malformed heart. Real-time three-dimensional echocardiography can be used to guide the location of bioptomes during right ventricular endomyocardial biopsies, placement of catheter-delivered valvular devices, and in many other intraoperative assessments.
Three-dimensional echocardiography technology may feature anatomical intelligence, or the use of organ-modeling technology, to automatically identify anatomy based on generic models. All generic models refer to a dataset of anatomical information that uniquely adapts to variability in patient anatomy to perform specific tasks. Built on feature recognition and segmentation algorithms, this technology can provide patient-specific three-dimensional modeling of the heart and other aspects of the anatomy, including the brain, lungs, liver, kidneys, rib cage, and vertebral column.
Contrast echocardiography, or contrast-enhanced ultrasound is the addition of an ultrasound contrast medium, or imaging agent, to traditional ultrasonography. The ultrasound contrast is made up of tiny microbubbles filled with a gas core and protein shell. This allows the microbubbles to circulate through the cardiovascular system and return the ultrasound waves, creating a highly reflective image. There are multiple applications in which contrast-enhanced ultrasound can be useful. The most commonly used application is in the enhancement of LV endocardial borders for assessment of global and regional systolic function. Contrast may also be used to enhance visualization of wall thickening during stress echocardiography, for the assessment of LV thrombus, or for the assessment of other masses in the heart. Contrast echocardiography has also been used to assess blood perfusion throughout myocardium in the case of coronary artery disease.
At the European level  individual and laboratory accreditation is provided by the European Association of Echocardiography (EAE). There are three subspecialties for individual accreditation: Adult Transthoracic Echocardiography (TTE), Adult Transesophageal Echocardiography (TEE) and Congenital Heart Disease Echocardiography (CHD).
In the UK, accreditation is regulated by the British Society of Echocardiography. Accredited radiographers, sonographers, or other professionals are required to pass a mandatory exam.
The "Intersocietal Accreditation Commission for Echocardiography” (IAC) sets standards for echo labs across the US. Cardiologists and sonographers who wish to have their laboratory accredited by IAC must comply with these standards. The purpose of accreditation is to maintain quality and consistency across echocardiography labs in the United States. Accreditation is offered in adult and pediatric transthoracic and transesophageal echocardiography, as well as adult stress and fetal echo. Accreditation is a two part process; first each facility will conduct a detailed self-evaluation, paying close attention to the IAC standards and Guidelines. The facility will then complete the application and submit actual case studies to the board of directors for review. Once all requirements have been met, the lab will receive IAC certification. IAC certification is a continual process and must be maintained by the facility, this may include audits or site visits by the IAC. There are several states in which Medicare and/or private insurance carriers are requiring either the accreditation of the laboratory and/or sonographer credentialing for reimbursement of echocardiograms.
There are two credentialing bodies in the United States for sonographers, the Cardiovascular Credentialing International (CCI), established in 1968, and the American Registry for Diagnostic Medical Sonography (ARDMS), established in 1975. Both CCI and ARDMS have earned the prestigious ANSI-ISO 17024 accreditation for certifying bodies from the International Organization for Standardization (ISO). Accreditation is granted through the American National Standards Institute (ANSI). Recognition of ARDMS programs in providing credentials has also earned the ARDMS accreditation with the National Commission for Certifying Agencies (NCCA). The NCCA is the accrediting arm of the National Organization for Competency Assurance (NOCA).
Under both credentialing bodies sonographers must first document completion of prerequisite requirements, which contain both didactic and hands-on experience in the field of ultrasound. Applicants must then take a comprehensive exam demonstrating knowledge in both the physics of ultrasound and the clinical competency related to their specialty. Credentialed sonographers are then required to maintain competency in their field by obtaining a certain number of Continuing Medical Education credits, or CME's.
In 2009, New Mexico and Oregon became the first two states to require licensure of sonographers.
The American Society of Echocardiography (ASE) is a professional organization made up of physicians, sonographers, nurses, and scientists involved in the field of echocardiography. One of the most important rolls that the ASE plays is providing their recommendations through the ASE Guidelines and Standards, providing a resource and educational opportunities for sonographers and physicians in the field.
- Oh, J. K. (2007-01-01). "Echocardiography in heart failure: Beyond diagnosis". European Journal of Echocardiography. 8 (1): 4–14. doi:10.1016/j.euje.2006.09.002. ISSN 1525-2167.
- Modin, Daniel; Andersen, Ditte Madsen; Biering-Sørensen, Tor (June 2018). "Echo and heart failure: when do people need an echo, and when do they need natriuretic peptides?". Echo Research and Practice. 5 (2): R65–R79. doi:10.1530/erp-18-0004.
- Batohi, Bhavna; Sidhu, Paul S. (2014). "The Development of Ultrasound for Clinical Use". In Thompson, Gilbert (ed.). Pioneers of Medicine Without a Nobel Prize. World Scientific. pp. 141–159. ISBN 978-1-78326-386-8. Retrieved 23 September 2016.
- Singh, Siddharth; Goyal, Abha (2007). "The origin of echocardiography: A Tribute to Inge Edler". Tex Heart Inst J. 34 (4): 431–438. PMC 2170493. PMID 18172524.
- Douglas, P. S.; Garcia, M. J.; Haines, D. E.; Lai, W. W.; Manning, W. J.; Patel, A. R.; Picard, M. H.; Polk, D. M.; Ragosta, M.; Ward, R. P.; Douglas, R. B.; Weiner, R. B.; Society for Cardiovascular Angiography Interventions; Society of Critical Care Medicine; American Society of Echocardiography; American Society of Nuclear Cardiology; Heart Failure Society of America; Society for Cardiovascular Magnetic Resonance; Society of Cardiovascular Computed Tomography; American Heart Association; Heart Rhythm Society (2011). "ACCF/ASE/AHA/ASNC/HFSA/HRS/SCAI/SCCM/SCCT/SCMR 2011 Appropriate Use Criteria for Echocardiography". Journal of the American College of Cardiology. 57 (9): 1126–1166. doi:10.1016/j.jacc.2010.11.002. PMID 21349406.
- American College of Cardiology, "Five Things Physicians and Patients Should Question" (PDF), Choosing Wisely: an initiative of the ABIM Foundation, American College of Cardiology, archived from the original (PDF) on June 24, 2012, retrieved August 17, 2012
- Poh KK, Levine RA, Solis J, et al. (October 2008). "Assessing aortic valve area in aortic stenosis by continuity equation: a novel approach using real-time three-dimensional echocardiography". Eur. Heart J. 29: 2526–35. doi:10.1093/eurheartj/ehn022. PMC 2721715. PMID 18263866.
- Goland S, Czer LS, Luthringer D, Siegel RJ (January 2008). "A case of arrhythmogenic right ventricular cardiomyopathy". Can J Cardiol. 24: 61–2. doi:10.1016/s0828-282x(08)70551-8. PMC 2631252. PMID 18209772.
- "Impact of Multiplanar Review of Three-Dimensional Echocardiographic Data on Management of Congenital Heart Disease". Ann. Thorac. Surg. 86: 875–881. 2008. doi:10.1016/j.athoracsur.2008.04.106.
- Platts D, Brown M, Javorsky G, West C, Kelly N, Burstow D (2010). "Comparison of Fluoroscopic versus Real Time Three-Dimensional Transthoracic Echocardiographic Guidance of Endomyocardial Biopsies". European Journal of Echocardiography. 11: 637–643. doi:10.1093/ejechocard/jeq036.
- Rodriguez, Gall. “Innovations Revolutionaize Medical Imaging”. NEMA electroindustry.
-  ESCardio
-  BSEcho - Exam
- Alsharqi, M; Woodward, W J; Mumith, J A; Markham, D C; Upton, R; Leeson, P (December 2018). "Artificial intelligence and echocardiography". Echo Research and Practice: R115–R125. doi:10.1530/ERP-18-0056. ISSN 2055-0464.